Phase 1two3
Seattle, WA
United States
ph: 206-201-2634

Services

Phase 1two3 provides hands-on assistance with corporate planning and execution on multiple levels.  This includes tasks from annual strategic planning to the more tactical details of executing a business plan or designing a clinical trial.   Contact our experienced professionals for help in analyzing your competition or performing due diligence on a new opportunity.  Let us complement your management team... we're here for you!

The capabilities of Phase 1two3's partners are enhanced by our outstanding associates, some of whom are listed on our "about us" page

  • Board of directors

    Phase 1two3 partners have extensive company operating experience, and have good contacts in finance and industry.  Some have served as officers of public and private companies.  We can put that experience to work for you and help guide your company to success.

  • Business Development

    Are you interested in augmenting your pipeline through  in-licensing, or do you need to out-license non-core assets?  We can help you with every step along the way, from opportunity identification and due diligence through negotiation, term sheet proposals and drafting of a final contract.

  • Business Plans

    Phase 1two3 partners have experience both writing and reviewing business plans.  We can help you maximize your chances of success with the financial community.

  • Clinical Strategy

    It is important to stay focused on drug approval and the market as you plan even early clinical trials.  Phase 1two3 partners can assist you in minimizing your clinical development costs and maximizing your return on your clinical investment.

  • Phase I, II or III Study Design

    Phase 1two3 partners can write protocols in areas of expertise, or review proposed protocols for their scientific integrity and merit.

  • Competitive Analysis

    Everyone needs to understand their competition.  Phase 1two3 can help you identify the technologies and companies active in your field, and analyze what relative strengths and advantages your technology demonstrates.

  • Corporate Development

    Phase 1two3 partners have extensive experience modelling potential outcomes for companies and determining the best pathway forward.

  • Drug Development Strategy

    Phase 1two3 believes it is important to have an integrated approach to drug development, including for example preclinical models for hypothesis testing, mechanism of action or technology validation, along with a robust clinical development plan, to maximize the chances of success in drug development.

  • Fundraising Strategy for Private Companies

    Phase 1two3 partners and associates have extensive experience with the venture community and can assist you in establishing a strategy to raise funds for your company.  There is no certainty in this difficult financial environment, but Phase 1two3 can help you navigate the shoals of venture financing.

  • Market Outlook

    Phase 1two3 can help you develop a market projection for your technology based on your business strategy and anticipated products.

  • Organizational development

    Underlying the important tasks faced by companies is the fact that success depends on people working effectively together.  Whether the team is engaged in strategic planning or discussing drug design, communication, teamwork, and the resolution of differences of opinion are critical.  Phase 1two3 can assist your team build the soft skills that accelerate the formation of a strong, well integrated, functional team and a winning organizational culture.

  • Preclinical Strategy

    Phase 1two3 has experience in designing preclinical studies to generate hypotheses to be tested clinically, as well as to generate news flow during drug development.

  • Regulatory Affairs

    Phase 1two3 can help you interpret and qualify FDA requirements, ensuring quality submisions which result in reduced review time and accelerated time to market.

  • Scientific Advisory Board

    Phase 1two3 has participated in scientific advisory boards and can assist you in the review of your scientific portfolio.

  • Scientific Due Diligence

    Partners of Phase 1two3 have performed extensive due diligence on a variety of biologics, devices, gene therapies and small molecules for in-licensing or investing.

  • Strategic Planning

    Interested in completing  your five year plan and tying it to short-term goals and objectives for company management? Let us assist you in establishing or updating your annual strategic planning process.I
As an example of recent contracts, Phase 1two3 helped write or rewrite  business plans for a device company, a small molecule company and a biologic company.  In all cases, a clinical strategy was developed from IND through Phase II and a competitive analysis performed, as well as assistance provided with budgeting.

Phase 1two3
Seattle, WA
United States
ph: 206-201-2634